Previous studies have identified factors such as blood calcium, T4 stage, N3 stage, p-III stage, non-squamous cell carcinoma, bone salivary protein BSP expression, elevated carcinoembryonic antigen levels, and high alkaline phosphatase as risk factors for bone metastasis in lung cancer (10, 11). The gene discussed is CEACAM5; the disease is bone metastasis.